{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T22:44:04Z","timestamp":1725489844617},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00417-017-3731-9","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T06:10:42Z","timestamp":1499235042000},"page":"1907-1916","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?"],"prefix":"10.1007","volume":"255","author":[{"given":"Kleanthis","family":"Manousaridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Peter-Reichart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Mennel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"3731_CR1","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The international Vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619","journal-title":"Ophthalmology"},{"key":"3731_CR2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al (2012) MIVI-TRUST study group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606\u2013615","journal-title":"N Engl J Med"},{"key":"3731_CR3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Simpson A, Angelis A, Grimaccia F, Kanavos P (2013) Symptomatic vitreomacular adhesion. Retina 33:1503\u20131511","journal-title":"Retina"},{"key":"3731_CR4","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1111\/j.1755-3768.2010.02101.x","volume":"89","author":"T Bertelmann","year":"2011","unstructured":"Bertelmann T, Ki\u010dov\u00e1 N, Messerschmidt-Roth A, Irle S, Sekundo W, Mennel S (2011) The vitreomacular interface in retinal vein occlusion. Acta Ophthalmol 89:e327\u2013e331","journal-title":"Acta Ophthalmol"},{"key":"3731_CR5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1755-3768.2008.01210.x","volume":"86","author":"S Schulze","year":"2008","unstructured":"Schulze S, Hoerle S, Mennel S, Kroll P (2008) Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol 86:470\u2013481","journal-title":"Acta Ophthalmol"},{"key":"3731_CR6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0029-1245448","volume":"228","author":"S Mennel","year":"2011","unstructured":"Mennel S, Meyer CH, Schmidt JC (2011) Der Einfluss des Glask\u00f6rpers auf die Pathogenese der altersabh\u00e4ngigen Makuladegeneration. Klin Monatsbl Augenheilkd 228:460\u2013464","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3731_CR7","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/IAE.0000000000000714","volume":"35","author":"R Krishnan","year":"2015","unstructured":"Krishnan R, Arora R, De Salvo G, Stinghe A, Severn PS, Pal B et al (2015) Vitreomacular traction affects anti-vascular endothelial growth factor treatment outcomes for exudative age- related macular degeneration. Retina 35:1750\u20131756","journal-title":"Retina"},{"key":"3731_CR8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/IAE.0000000000000663","volume":"35","author":"SK Houston III","year":"2015","unstructured":"Houston SK III, Rayess N, Cohen MN, Ho AC, Regillo CD (2015) Influence of vitreomacular interface on anti- vascular endothelial growth factor therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX). Retina 35:1757\u20131764","journal-title":"Retina"},{"key":"3731_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s004170100259","volume":"239","author":"CH Meyer","year":"2001","unstructured":"Meyer CH, Toth CA (2001) Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 239:325\u2013333","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3731_CR10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/eye.2008.84","volume":"22","author":"DA Laidlaw","year":"2008","unstructured":"Laidlaw DA (2008) Vitrectomy for diabetic macular oedema. Eye (Lond) 22:1337\u20131341","journal-title":"Eye (Lond)"},{"key":"3731_CR11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"JA Haller","year":"2010","unstructured":"Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ et al (2010) Diabetic retinopathy clinical research network writing committee. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117:1087\u20131093","journal-title":"Ophthalmology"},{"key":"3731_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0032-1328668","volume":"230","author":"KU Barzt-Schmidt","year":"2013","unstructured":"Barzt-Schmidt KU, Bertram N, Bornfeld N, Bresgen M, Eter N, Feltgen N et al (2013) Aktuelle Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands zur therapeutischen intravitrealen Anwendung von Ocriplasmin (JETREA) in der Augenheilkunde. Klin Monatsbl Augenheilkd 230:629\u2013634","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3731_CR13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajo.2014.01.011","volume":"157","author":"GP Theodossiadis","year":"2014","unstructured":"Theodossiadis GP, Grigoropoulos VG, Theodoropoulou S, Datseris I, Theodossiadis PG (2014) Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography. Am J Ophthalmol 157:842\u2013851","journal-title":"Am J Ophthalmol"},{"key":"3731_CR14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","volume":"98","author":"RP Singh","year":"2014","unstructured":"Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP et al (2014) Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol 98:356\u2013360","journal-title":"Br J Ophthalmol"},{"key":"3731_CR15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ajo.2015.01.034","volume":"159","author":"P Sharma","year":"2015","unstructured":"Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho A, Regillo C (2015) Efficacy of intravitreal ocriplasmin on vitreomacular traction and full thickness macular holes. Am J Ophthalmol 159:861\u2013867","journal-title":"Am J Ophthalmol"},{"key":"3731_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0034-1368372","volume":"231","author":"AP Lommatzsch","year":"2014","unstructured":"Lommatzsch AP, Gutfleisch M, Dietzel M, Heimes B, Spital G, B\u00f6hme M et al (2014) Erste klinische Erfahrungen bei der Behandlung von vitreomakul\u00e4ren Traktionen mit Ocriplasmin. Klin Monatsbl Augenheilkd 231:909\u2013914","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3731_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00417-015-3031-1","volume":"254","author":"I Chatziralli","year":"2016","unstructured":"Chatziralli I, Theodossiadis G, Parikakis E, Datseris I, Theodossiadis P (2016) Real life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study. Graefes Arch Clin Exp Ophthalmol 254:223\u2013233","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"3731_CR18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20130715-05","volume":"44","author":"BT Kim","year":"2013","unstructured":"Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM et al (2013) Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina 44(4):334\u2013343","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3731_CR19","doi-asserted-by":"publisher","unstructured":"Feng HL, Roth DB, Hasan A, Fine HF, Wheatley M, Prenner JL et al (2017) Intravitreal ocriplasmin in clinical practice. Predictors of success, visual outcomes, and complications. Retina. doi:\n10.1097\/IAE.0000000000001505","DOI":"10.1097\/IAE.0000000000001505"},{"key":"3731_CR20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/eye.2016.42","volume":"30","author":"DHW Steel","year":"2016","unstructured":"Steel DHW, Parkes C, Papastavrou VT, Avery PJ, El-Ghrably IA, Habib MS et al (2016) Predicting macular hole closure with ocriplasmin based on spectral domain optical coherence tomography. Eye 30:740\u2013745","journal-title":"Eye"},{"key":"3731_CR21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bjophthalmol-2014-305620","volume":"99","author":"A Hager","year":"2015","unstructured":"Hager A, Seibel I, Riechardt A, Rehak M, Joussen AM (2015) Does ocriplasmin affect the RPE-photoreceptor adhesion in macular holes? Br J Ophthalmol 99:635\u2013638","journal-title":"Br J Ophthalmol"},{"key":"3731_CR22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/IAE.0000000000000542","volume":"35","author":"B Reiss","year":"2015","unstructured":"Reiss B, Smithen L, Mansour S (2015) Transient vision loss after ocriplasmin injection. Retina 35:1107\u20131110","journal-title":"Retina"},{"key":"3731_CR23","unstructured":"Paul C, Heun C, M\u00fcller HH, Fauser S, Kaymak H, Kazerounian S et al (2016) Impact of vitreoretinal interface architecture on successful vitreomacular traction resolution in eyes scheduled for intravitreal ocriplasmin therapy. Retina. 2016 Oct 26. [Epub ahead of print]"},{"key":"3731_CR24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ajo.2007.07.024","volume":"144","author":"I Krebs","year":"2007","unstructured":"Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S (2007) Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 144:741\u2013746","journal-title":"Am J Ophthalmol"},{"key":"3731_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0420.2001.790502.x","volume":"79","author":"E Stefansson","year":"2001","unstructured":"Stefansson E (2001) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79:435\u2013440","journal-title":"Acta Ophthalmol Scand"},{"key":"3731_CR26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-9394(67)90557-0","volume":"64","author":"AB Reese","year":"1967","unstructured":"Reese AB, Jones IS, Cooper WC (1967) Macular changes secondary to vitreous traction. Am J Ophthalmol 64:544\u2013549","journal-title":"Am J Ophthalmol"},{"key":"3731_CR27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ophtha.2015.02.031","volume":"122","author":"TA Ciulla","year":"2015","unstructured":"Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE et al (2015) Comparison of age-related macular degeneration treatments trials research group. Influence of the Vitreomacular Interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122:1203\u20131211","journal-title":"Ophthalmology"},{"key":"3731_CR28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3341\/kjo.2015.29.6.396","volume":"29","author":"KH Lee","year":"2015","unstructured":"Lee KH, Chin HS, Kim NR, Moon YS (2015) Effects of Vitreomacular traction on Ranibizumab treatment response in eyes with Neovascular age-related macular degeneration. Korean J Ophthalmol 29:396\u2013403","journal-title":"Korean J Ophthalmol"},{"key":"3731_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-0420.2006.00703.x","volume":"84","author":"CH Meyer","year":"2006","unstructured":"Meyer CH, Mennel S, Schmidt JC (2006) Occult vitreo-macular traction may cause traumatic RPE tears. Acta Ophthalmol Scand 84:560","journal-title":"Acta Ophthalmol Scand"},{"key":"3731_CR30","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/bjo.2006.094201","volume":"90","author":"JC Schmidt","year":"2006","unstructured":"Schmidt JC, Mennel S, Hoerle S, Meyer CH (2006) High incidence of vitreomacular traction in recurrent choroidal neovascularization after repeated photodynamic therapy. Br J Ophthalmol 90:1361\u20131362","journal-title":"Br J Ophthalmol"},{"key":"3731_CR31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/IAE.0b013e3180654229","volume":"27","author":"PA Quiram","year":"2007","unstructured":"Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT (2007) Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 27:1090\u20131096","journal-title":"Retina"},{"key":"3731_CR32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/IAE.0b013e318180ab29","volume":"28","author":"E Stefansson","year":"2008","unstructured":"Stefansson E (2008) Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 28:1175\u20131176","journal-title":"Retina"},{"key":"3731_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bjo.2005.072934","volume":"90","author":"SP Shah","year":"2006","unstructured":"Shah SP, Patel M, Thomas D, Aldington S, Laidlaw DA (2006) Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol 90:33\u201336","journal-title":"Br J Ophthalmol"},{"key":"3731_CR34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9394(14)72159-2","volume":"120","author":"JW Harbour","year":"1995","unstructured":"Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW Jr (1995) Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 120:302\u2013307","journal-title":"Am J Ophthalmol"},{"key":"3731_CR35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1055\/s-0032-1331542","volume":"229","author":"T Bertelmann","year":"2012","unstructured":"Bertelmann T, Witteborn M, Mennel S (2012) Das pseudophakiebedingte zystoide Makula\u00f6dem. Klin Monatsbl Augenheilkd 229:798\u2013781","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3731_CR36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2014.10.006","volume":"122","author":"RL Novack","year":"2015","unstructured":"Novack RL, Staurenghi G, Girach A, Narendran N, Tolentino M (2015) Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration. Ophthalmology 122:796\u2013802","journal-title":"Ophthalmology"},{"key":"3731_CR37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ajo.2008.01.001","volume":"145","author":"HM Wheatley","year":"2008","unstructured":"Wheatley HM (2008) Posterior vitreomacular adhesion and exudative age-related macular degeneration. Am J Ophthalmol 145:765","journal-title":"Am J Ophthalmol"},{"key":"3731_CR38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00006982-200504000-00010","volume":"25","author":"N Matsunaga","year":"2005","unstructured":"Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y (2005) Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 25:311\u2013316","journal-title":"Retina"},{"key":"3731_CR39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","volume":"139","author":"A Gandorfer","year":"2005","unstructured":"Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A (2005) Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 139:638\u2013652","journal-title":"Am J Ophthalmol"},{"key":"3731_CR40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4103\/0301-4738.143936","volume":"62","author":"V Tah","year":"2014","unstructured":"Tah V, Keane PA, Esposti SD, Allimuthu J, Chen FK, Da Cruz L et al (2014) Repeatability of retinal thickness and volume metrics in neovascular age-related macular degeneration using the Topcon 3DOCT-1000. Indian J Ophthalmol 62:941\u2013948","journal-title":"Indian J Ophthalmol"},{"key":"3731_CR41","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1167\/iovs.09-4976","volume":"51","author":"M Parravano","year":"2010","unstructured":"Parravano M, Oddone F, Boccassini B, Menchini F, Chiaravalloti A, Schiavone M, Varano M (2010) Reproducibility of macular thickness measurements using cirrus SD-OCT in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 51:4788\u20134791","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3731_CR42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/IAE.0000000000000448","volume":"35","author":"PK Kaiser","year":"2015","unstructured":"Kaiser PK, Kampik A, Kuppermann BD, Girach A, Rizzo S, Sergott RC (2015) Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion\/traction. Retina 35:1111\u20131127","journal-title":"Retina"},{"key":"3731_CR43","doi-asserted-by":"publisher","unstructured":"Chan CK, Crosson JN, Mein CE, Daher N (2017) Pneumatic vitreolysis for relief of vitreomacular traction. Retina. doi:\n10.1097\/IAE.0000000000001448","DOI":"10.1097\/IAE.0000000000001448"},{"key":"3731_CR44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/IAE.0000000000001237","volume":"37","author":"NC Steinle","year":"2017","unstructured":"Steinle NC, Dhoot DS, Quezada Ruiz C, Castellarin AA, Pieramici DJ, See RF et al (2017) Treatment of vitreomacular traction with intravitreal perfluoropropane (C3F8) injection. Retina 37:643\u2013650","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3731-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T04:02:50Z","timestamp":1505534570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3731-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]}}}